Neochord Info Sheet

Listing Results Neochord Info Sheet

About 19 results and 4 answers.

Home NeoChord

NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. NeoChord

Show more

See More

About Us NeoChord

info@NeoChord.com. NeoChord, Inc 5402 Parkdale Drive, Suite 160 St. Louis Park, MN 55416. Close product quick view ...

Show more

See More

NeoChord Minimally Invasive Mitral Valve Repair Mitral

Aug 14, 2018 . The NeoChord device, in illustration, is inserted in the beating heart through a small incision, guided by echocardiography “While the heart is beating, you make a small incision under the patient’s left nipple, insert the device, and implant the artificial chords to the mitral valve,” says Dr. El-Eshmawi, the site Principal Investigator for the study.

Show more

See More

NeoChord - Crunchbase Company Profile & Funding

NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation. In contrast, most mitral valve repair procedures are performed through a 3 to 10-inch chest
Founder: John Seaberg
Location: Saint Louis Park, Minnesota
Founded: Jul 01, 2007

Show more

See More

NeoChord Mitral Valve Repair Device

Jan 08, 2013 . Learn about the NeoChord Mitral Valve Repair device used to replace damaged or defect chordae in the patient's heart using a catheter-based approach.

Show more

See More

neoChord DS1000 - YouTube

Digital animation of beating-heart, sternal-sparing implantation of artificial chordae tendineae enabled by NeoChord's surgical device -- a minimally-invasiv...

Show more

See More

Fact Sheet for Recipients - Pfizer-BioNTech COVID-19

Jan 03, 2022 . 1 revised: 03 january 2022 . vaccine information fact sheet for recipients and caregivers about comirnaty (covid-19 vaccine, mrna) and the pfizer-biontech covid-19 vaccine to prevent coronavirus
NeoChord

Show more

See More

Transapical neochord implantation: Is tension of

Jul 01, 2014 . The NeoChord tension and pressure signals were recorded and converted to digital data using an analogue-to-digital converter with a sampling frequency of 1300 Hz (s −1) controlled by dedicated software developed in LabVIEW (National Instruments, Austin, Tex). Zero adjustment of the chordae force signals was accomplished during sustained vena cava …

Show more

See More

NeoChord Company Profile - Office Locations, Competitors

NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3 inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation.

Show more

See More

Randomized Trial of the Neochord DS1000 System Versus Open

Jun 17, 2016 . Randomized Trial of the NeoChord DS1000 System Versus Open Surgical Repair (ReChord) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by …

Show more

See More

Jobs with NeoChord

Oct 28, 2016 . NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, today announced successful completion of the first-in-human procedure with the NeoChord NeXuS Transcatheter Mitral Chordal Repair technology (TMVr).

Show more

See More

Transcatheter Chordal Repair for Degenerative Mitral

NeoChord SYSTEM. Transapical off-pump MVR with NeoChord implantation is performed with the NeoChord DS1000 system using two-dimensional (2D) and three-dimensional (3D) transesophageal echocardiographic (TEE) guidance for prolapse and/or flail treatment of the anterior and/or posterior mitral leaflets . 4-6

Show more

See More

Google Sheets: Sign-in

Access Google Sheets with a free Google account (for personal use) or Google Workspace account (for business use).
NeoChord

Show more

See More

Alex Jonkers - Chief Commercial Officer - NeoChord, Inc

Chief Commercial Officer at NeoChord, Inc. Eindhoven, Noord-Brabant, Nederland Meer dan 500 connecties. Lid worden en connectie maken NeoChord, Inc. Open Universiteit Nederland. Dit profiel melden Info Specialties: International sales and clinical experience Start up companies ...
Title: Chief Commercial Officer at …
Location: Eindhoven, Noord-Brabant, Nederland

Show more

See More

Safety and Performance Study of the NeoChord Device - Full

Jan 29, 2013 . Layout table for additonal information; Responsible Party: NeoChord: ClinicalTrials.gov Identifier: NCT01777815 Other Study ID Numbers: PR-610404-100 09/1819 ( Other Identifier: FEKI ) First Posted: January 29, 2013 Key Record Dates: Last Update Posted: September 25, 2014 ...

Show more

See More

Mitral valve repair using adjustable posterior leaflet

The novel element of our method is that the looped NeoChord is secured behind the annulus and on the atrial side—a modification that imparts several benefits over alternative techniques. The added traction on the NeoChord as it passes behind the annulus allows the surgeon to place the NeoChord, implant the annuloplasty ring, and test the valve without having to permanently …

Show more

See More

NeoChord Inc. :: Medtech Insight

Jul 01, 2008 . NeoChord wants to enable less invasive mitral valve repair with the NeoChord DS1000 is a tool for implanting artificial chordae tendineae made of suturing material while the heart is still beating. You may also be interested in...

Show more

See More

Neochord DS1000 System Successfully Treats 20th Patient in

Apr 30, 2018 . The NeoChord procedure is a mitral valve chordal repair technique that is performed on a beating heart via a thoracotomy. Nearly 1,000 patients have been treated with the NeoChord procedure to date.

Show more

See More

Frequently Asked Questions

  • What is neoneochord?

    NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company’s flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.

  • What is neochord artificial chordae delivery?

    The NeoChord Artificial Chordae Delivery System is a beating heart procedure, echo-guided treatment option for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. This opens in a new window.

  • What is neochord mitral valve repair device?

    Tech Update: NeoChord Mitral Valve Repair Device Gets CE Mark. This unique device, which is not FDA approved in America, enables minimally invasive implantation of artificial chordae using a catheter-based approach. If you did not know, the chordae support the mitral valve leaflets as they open-and-close to move the blood through your heart.

  • Is there a clinical trial for neochord DS1000?

    A clinical study is ongoing within the United States to evaluate the use of the NeoChord DS1000. Mount Sinai Heart is leading a multicenter clinical trial of a minimally invasive mitral valve prolapse repair technology that has the potential to transform the standard of care for the disorder.

Have feedback?

If you have any questions, please do not hesitate to ask us.